Pall Corporation and Aetos Biologics Partner to Deliver Integrated, Off-the-Shelf Biosimilar Manufacturing Solutions
PORT WASHINGTON, N.Y., Sept. 12, 2018 /PRNewswire/ — Pall Corporation, a global leader in filtration, separation and purification, has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company. The companies will collaborate to offer biosimilar manufacturing solutions to the global biosimilars market. Pall Biotech will... Read more